| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38e29b14d2523d963e06cd3132596960 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16634 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3986daf0113ea33b06b560ebd60418a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3de3410256c598affa9b7e6bb2cacdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25a7a19befda49ac4ed3a90cfd112d3 |
| publicationDate |
2017-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
LU-92998-B1 |
| titleOfInvention |
Means and methods for treating HSV |
| abstract |
The present invention relates to a vaccine composition comprising a multimeric complex of Herpes Simplex Virus (HSV) polypeptides for the treatment or vaccination against HSV. The present invention also relates to a vector comprising a polynucleotide encoding the HSV polypeptides and a host cell comprising the vector. The present invention further comprises a method for producing the vaccine composition. 92998 |
| priorityDate |
2016-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |